SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-107882
Filing Date
2016-06-10
Accepted
2016-06-10 16:21:30
Documents
1
Period of Report
2016-06-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v442155_4.html 4  
1 OWNERSHIP DOCUMENT v442155_4.xml 4 5713
  Complete submission text file 0001144204-16-107882.txt   7266
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 AVENUE DE L?OPERA PARIS I0 75002
Business Address 47 AVENUE DE L?OPERA PARIS I0 75002 01-83-79-81-91
Ventech Capital II (Reporting) CIK: 0001604072 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 161708899